Generic drug
Deferasirox price, strengths & recalls
Pharmacies pay $33.58 for 30 tablets of Deferasirox 360 mg tablet this week, and from $33.58 to $175.57 across its 2 priced strengths and forms. 13 manufacturers make it. 1 recall is ongoing. Its official label last changed on December 4, 2024.
1 open recallGeneric- Fair cash price
- $49.12
- Strengths
- 2
- Makers
- 13
- Updated
- Nov 11
Deferasirox price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 180 mg tablet | Not priced this week | |||
| 360 mg tablet | $1.12 | $33.58 / 30 tablets | ||
| 500 mg tablet for oral suspension | $5.85 | $175.57 / 30 tablets | ||
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Deferasirox
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use DEFERASIROX TABLETS safely and effectively. See full prescribing information for DEFERASIROX TABLETS. DEFERASIROX tablets, for oral use Initial U.S. Approval: 2005
WARNING: RENAL FAILURE, HEPATIC FAILURE, AND GASRTOINTESTINAL HEMORRHAGE
Renal Failure
Deferasirox can cause acute renal failure and death, particularly in patients with comorbidities and those who are in the advanced stages of their hematologic disorders.
Evaluate baseline renal function prior to starting or increasing deferasirox dosing in all patients. Deferasirox is contraindicated in adult and pediatric patients with eGFR less than 40 mL/min/1.73 m2. Measure serum creatinine in duplicate prior to initiation of therapy. Monitor renal function at least monthly. For patients with baseline renal impairment or increased risk of acute renal failure, monitor renal function weekly for the first month, then at least monthly. Reduce the starting dose in patients with preexisting renal disease. During therapy, increase the frequency of monitoring and modify the dose for patients with an increased risk of renal impairment, including use of concomitant nephrotoxic drugs, and pediatric patients with volume depletion or overchelation [see Dosage and Administration (2.1, 2.4, 2.5), Warnings and Precautions (5.1), Adverse Reactions (6.1, 6.2)].
Hepatic Failure
Deferasirox can cause hepatic injury including hepatic failure and death.
Measure serum transaminases and bilirubin in all patients prior to initiating treatment, every 2 weeks during the first month, and at least monthly thereafter.
Avoid use of deferasirox in patients with severe (Child-Pugh C) hepatic impairment and reduce the dose in patients with moderate (Child-Pugh B) hepatic impairment [see Dosage and Administration (2.4), Warnings and Precautions (5.2)].
Gastrointestinal Hemorrhage
Deferasirox can cause gastrointestinal (GI) hemorrhages, which may be fatal, especially in elderly patients who have advanced hematologic malignancies and/or low platelet counts.
Monitor patients and discontinue deferasirox for suspected GI ulceration or hemorrhage [see Warnings and Precautions (5.3)].
WARNING: RENAL FAILURE, HEPATIC FAILURE, AND GASTROINTESTINAL HEMORRHAGE
See full prescribing information for complete boxed warning.
Deferasirox may cause serious and fatal:
acute kidney injury, including acute renal failure requiring dialysis and renal tubular toxicity including Fanconi syndrome (5.1)
hepatic toxicity, including failure (5.2)
gastrointestinal hemorrhage (5.3)
Deferasirox therapy requires close patient monitoring, including laboratory tests of renal and hepatic function. (5)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 13 approved generic applications on the market
Deferasirox questions
How much does deferasirox cost without insurance?
Pharmacies pay about $33.58 for 30 tablets of deferasirox 360 mg tablet ($1.12 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $49.12. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is deferasirox in shortage?
No shortage is reported for deferasirox right now. We check the national shortage list every day.
Has deferasirox been recalled?
1 recall on record, 1 ongoing. Recalls name specific lots - check yours.
When did the deferasirox label last change?
The official label was last updated on December 4, 2024 (version 5). See what changed.
Talk about deferasirox
No comments yet. Questions, tips, what worked for you - start the conversation.